Q32 Bio (QTTB) Competitors $32.95 -2.68 (-7.52%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends QTTB vs. HRMY, NRIX, IRON, GLPG, TARS, ARVN, IMCR, SYRE, XNCR, and OCULShould you be buying Q32 Bio stock or one of its competitors? The main competitors of Q32 Bio include Harmony Biosciences (HRMY), Nurix Therapeutics (NRIX), Disc Medicine (IRON), Galapagos (GLPG), Tarsus Pharmaceuticals (TARS), Arvinas (ARVN), Immunocore (IMCR), Spyre Therapeutics (SYRE), Xencor (XNCR), and Ocular Therapeutix (OCUL). These companies are all part of the "pharmaceutical products" industry. Q32 Bio vs. Harmony Biosciences Nurix Therapeutics Disc Medicine Galapagos Tarsus Pharmaceuticals Arvinas Immunocore Spyre Therapeutics Xencor Ocular Therapeutix Q32 Bio (NASDAQ:QTTB) and Harmony Biosciences (NASDAQ:HRMY) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Does the media favor QTTB or HRMY? In the previous week, Harmony Biosciences had 5 more articles in the media than Q32 Bio. MarketBeat recorded 7 mentions for Harmony Biosciences and 2 mentions for Q32 Bio. Harmony Biosciences' average media sentiment score of 0.66 beat Q32 Bio's score of 0.03 indicating that Harmony Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Q32 Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Harmony Biosciences 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in QTTB or HRMY? 31.3% of Q32 Bio shares are owned by institutional investors. Comparatively, 86.2% of Harmony Biosciences shares are owned by institutional investors. 16.1% of Q32 Bio shares are owned by insiders. Comparatively, 30.8% of Harmony Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is QTTB or HRMY more profitable? Harmony Biosciences has a net margin of 17.98% compared to Q32 Bio's net margin of 0.00%. Harmony Biosciences' return on equity of 23.16% beat Q32 Bio's return on equity.Company Net Margins Return on Equity Return on Assets Q32 BioN/A -146.18% -54.49% Harmony Biosciences 17.98%23.16%14.24% Which has more volatility and risk, QTTB or HRMY? Q32 Bio has a beta of -0.32, indicating that its stock price is 132% less volatile than the S&P 500. Comparatively, Harmony Biosciences has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Do analysts recommend QTTB or HRMY? Q32 Bio currently has a consensus price target of $72.33, suggesting a potential upside of 119.52%. Harmony Biosciences has a consensus price target of $47.00, suggesting a potential upside of 41.50%. Given Q32 Bio's stronger consensus rating and higher probable upside, research analysts clearly believe Q32 Bio is more favorable than Harmony Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Q32 Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Harmony Biosciences 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.56 Which has higher earnings & valuation, QTTB or HRMY? Harmony Biosciences has higher revenue and earnings than Q32 Bio. Q32 Bio is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQ32 Bio$1.16M345.98-$112.96M-$14.25-2.31Harmony Biosciences$582.02M3.25$128.85M$2.1115.74 Does the MarketBeat Community believe in QTTB or HRMY? Harmony Biosciences received 46 more outperform votes than Q32 Bio when rated by MarketBeat users. However, 100.00% of users gave Q32 Bio an outperform vote while only 66.25% of users gave Harmony Biosciences an outperform vote. CompanyUnderperformOutperformQ32 BioOutperform Votes7100.00% Underperform VotesNo VotesHarmony BiosciencesOutperform Votes5366.25% Underperform Votes2733.75% SummaryHarmony Biosciences beats Q32 Bio on 14 of the 19 factors compared between the two stocks. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get Q32 Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for QTTB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QTTB vs. The Competition Export to ExcelMetricQ32 BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$401.36M$6.49B$5.13B$8.74BDividend YieldN/A8.15%5.18%4.07%P/E Ratio-2.314.8266.7313.27Price / Sales345.98374.171,265.2981.14Price / CashN/A51.8140.2135.77Price / Book21.979.636.455.92Net Income-$112.96M$154.43M$119.73M$225.73M7 Day Performance-27.25%-9.46%-5.13%-1.34%1 Month Performance-33.62%-7.27%-2.71%1.15%1 Year PerformanceN/A28.13%31.08%24.02% Q32 Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QTTBQ32 Bio2.0011 of 5 stars$32.95-7.5%$72.33+119.5%N/A$401.36M$1.16M-2.3139HRMYHarmony Biosciences4.8494 of 5 stars$33.84-3.5%N/A+28.5%$1.93B$582.02M16.04200Short Interest ↓NRIXNurix Therapeutics2.6769 of 5 stars$27.15+0.4%N/A+277.6%$1.92B$76.99M-9.33300Positive NewsIRONDisc Medicine3.1956 of 5 stars$63.06-0.3%N/A+23.0%$1.87BN/A-15.8478Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageGLPGGalapagos1.6033 of 5 stars$27.56+0.9%N/A-27.5%$1.82B$259.40M0.001,123Short Interest ↓TARSTarsus Pharmaceuticals1.7501 of 5 stars$46.51-2.2%N/A+152.8%$1.77B$17.45M-10.3850Analyst ForecastAnalyst RevisionNews CoverageARVNArvinas2.3286 of 5 stars$25.34-3.7%N/A+8.1%$1.74B$78.50M-5.43445Short Interest ↓IMCRImmunocore2.9264 of 5 stars$34.17+1.2%N/A-32.6%$1.71B$249.43M-35.97497Gap DownSYRESpyre Therapeutics2.6745 of 5 stars$32.98-7.9%N/AN/A$1.70B$890,000.00-4.41100Analyst ForecastAnalyst RevisionNews CoverageXNCRXencor3.604 of 5 stars$23.61-0.4%N/A+24.4%$1.66B$85.16M-7.38280Insider SellingOCULOcular Therapeutix4.0252 of 5 stars$10.60flatN/A+340.4%$1.65B$61.10M-7.85267Analyst ForecastNews Coverage Related Companies and Tools Related Companies Harmony Biosciences Competitors Nurix Therapeutics Competitors Disc Medicine Competitors Galapagos Competitors Tarsus Pharmaceuticals Competitors Arvinas Competitors Immunocore Competitors Spyre Therapeutics Competitors Xencor Competitors Ocular Therapeutix Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QTTB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Q32 Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QTTB Stock Alerts